https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2016-06-07 / Int J Hyperthermia 2016 09;32(6):648-56
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2016-06-07 / Int J Hyperthermia 2016 09;32(6):648-562016-06-07 00:00:002019-03-27 11:35:26Electro-hyperthermia up-regulates tumour suppressor Septin 4 to induce apoptotic cell death in hepatocellular carcinoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2016-06-05 / J Clin Oncol 34, 2016 (suppl; abstr e12566)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2016-06-05 / J Clin Oncol 34, 2016 (suppl; abstr e12566)2016-06-05 12:12:422019-07-17 12:13:35Dendritic cells-based vaccine to inhibit triple-negative breast cancer cells proliferation.
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2016-06-05 / J Clin Oncol 34, 2016 (suppl; abstr 1086)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2016-06-05 / J Clin Oncol 34, 2016 (suppl; abstr 1086)2016-06-05 12:10:572019-07-17 12:11:24Safety and initial clinical efficacy of a dendritic cell (DC) vaccine in locally advanced, triple-negative breast cancer (TNBC) patients (pts).
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2016-06-05 / J Clin Oncol 34, 2016 (suppl; abstr 1081)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2016-06-05 / J Clin Oncol 34, 2016 (suppl; abstr 1081)2016-06-05 12:10:062019-07-17 12:10:27Impact of CD8 stromal lymphocytes in BC patients with the addition of autologous dendritic CELL vaccination to neoadjuvant chemotherapy.
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2016-06-05 / J Clin Oncol 34, 2016 (suppl; abstr 3090)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2016-06-05 / J Clin Oncol 34, 2016 (suppl; abstr 3090)2016-06-05 11:38:422019-07-17 11:39:065-year follow up for 72 metastatic melanoma patients treated with eltrapuldencel-T (CLBS20) vaccine.
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2016-06-04 / J Clin Oncol 34, 2016 (suppl; abstr 2039)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2016-06-04 / J Clin Oncol 34, 2016 (suppl; abstr 2039)2016-06-04 12:03:342019-07-17 12:03:56Association of increased survival in glioblastoma patients treated with dendritic cell vaccinations and temozolomide with increased activity of NK cells and ABCC3 expression.
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2016-06-03 / J Clin Oncol 34, 2016 (suppl; abstr e14571)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2016-06-03 / J Clin Oncol 34, 2016 (suppl; abstr e14571)2016-06-03 00:00:002016-06-03 00:00:00Immune effects by selective heating of membrane rafts of cancer-cells.
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2016-06-03 / J Clin Oncol 34, 2016 (suppl; abstr e14586)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2016-06-03 / J Clin Oncol 34, 2016 (suppl; abstr e14586)2016-06-03 00:00:002016-06-03 00:00:00Dendritic cell vaccine transduced with ubiquitin-mesothelin fusion gene for pancreatic cancer.
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2016-06-03 / J Clin Oncol 34, 2016 (suppl; abstr e14579)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2016-06-03 / J Clin Oncol 34, 2016 (suppl; abstr e14579)2016-06-03 00:00:002016-06-03 00:00:00A feasibility and safety study of vaccination with Poly-ICLC and peptide-pulsed dendritic cells in patients with advanced pancreatic adenocarcinoma.
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2016-06-03 / BJU Int. 2016 10;118(4):506-14
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2016-06-03 / BJU Int. 2016 10;118(4):506-142016-06-03 00:00:002019-02-15 08:52:00Recent advances in immuno-oncology and its application to urological cancers
